Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy
Age-related macular degeneration (AMD) is a growing public health concern given the aging population and it is the leading cause of blindness in developed countries, affecting individuals over the age of 55 years. AMD affects the retinal pigment epithelium (RPE) and Bruch’s membrane in the macula, l...
Հիմնական հեղինակներ: | Borchert, GA, Shamsnajafabadi, H, Ng, BWJ, Xue, K, De Silva, SR, Downes, SM, MacLaren, RE, Cehajic-Kapetanovic, J |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
Frontiers Media
2024
|
Նմանատիպ նյութեր
-
Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy
: Grace A. Borchert, և այլն
Հրապարակվել է: (2024-07-01) -
The Role of Inflammation in Age-Related Macular Degeneration—Therapeutic Landscapes in Geographic Atrophy
: Grace A. Borchert, և այլն
Հրապարակվել է: (2023-08-01) -
Optogenetic Gene Therapy for the Degenerate Retina: Recent Advances
: Michelle E. McClements, և այլն
Հրապարակվել է: (2020-11-01) -
Real-world six-month outcomes in patients switched to faricimab following partial response to anti-VEGF therapy for neovascular age-related macular degeneration and diabetic macular oedema
: Borchert, GA, և այլն
Հրապարակվել է: (2024) -
Current and Future Landscape in Genetic Therapies for Leber Hereditary Optic Neuropathy
: Hoda Shamsnajafabadi, և այլն
Հրապարակվել է: (2023-08-01)